Business Segments Bayer AG

Equities

Market Closed - Xetra Other stock markets 16:37:35 17/04/2026 BST			5-day change	1st Jan Change
41.10 ^EUR	+1.01%		+2.44%	+11.05%

12:00am	US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims	RE
11:48pm	U.S. judge rejects Bayer's request for injunction to block Johnson & Johnson's alleged false statements about prostate cancer drug	RE

Breakdown by Business Segment (EUR)

Fiscal Period: December	2021	2022	2023	2024	2025
Nitrogenous Fertilizers
Crop Science	20.22B	25.18B	23.29B	22.31B	21.68B
Total Assets	-	-	-	-	-
CAPEX	-1.24B	-1.79B	-1.6B	-1.45B	-1.31B
EBITDA	4.7B	6.87B	5.04B	4.32B	4.19B
D&A	2.26B	4.6B	2.37B	2.47B	2.58B
Operating Income	-495M	2.95B	-3.49B	-2.76B	-2.53B
Pharmaceutical Products
Pharmaceuticals	18.37B	19.26B	18.11B	18.17B	17.83B
Total Assets	-	-	-	-	-
CAPEX	-1.31B	-1.32B	-1.21B	-1.29B	-1.12B
EBITDA	5.78B	5.87B	5.19B	4.72B	4.52B
D&A	871M	1.23B	908M	935M	933M
Operating Income	4.47B	4.98B	3.97B	2.79B	3.13B
Non-Prescription Drugs
Consumer Health	5.29B	6.08B	6.03B	5.88B	5.81B
Total Assets	-	-	-	-	-
CAPEX	-207M	-200M	-171M	-206M	-208M
EBITDA	1.19B	1.37B	1.41B	1.37B	1.34B
D&A	331M	364M	361M	376M	376M
Operating Income	808M	957M	1.16B	1.03B	912M
Outsourced Business Services
All Other	203M	219M	239M	328M	303M
Total Assets	-	-	-	-	-
CAPEX	-93M	-43M	-105M	-71M	-243M
EBITDA	95M	151M	163M	62M	277M
D&A	69M	71M	67M	72M	80M
Operating Income	-27M	79M	96M	-11M	196M
Enabling Functions and Consolidation	-5M	-1M	-36M	-72M	-48M
Total Assets	-	-	-	-	-
CAPEX	-156M	-293M	-241M	-237M	-267M
EBITDA	-583M	-745M	-95M	-352M	-662M
D&A	212M	245M	201M	199M	200M
Operating Income	-1.4B	-1.96B	-1.13B	-1.12B	-2.78B
Total Assets	-	-	-	-	-
Plastic and Synthetic Resins
Covestro	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Veterinary Drugs
Animal Health	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (EUR)

Fiscal Period: December	2021	2022	2023	2024	2025
United States	13.4B	15.68B	14.59B	14.8B	15.1B
Total Assets	48B	46.24B	39.52B	37.12B	34.74B
Europe / Middle East / Africa (Excl. Germany & Switzerland)	10.56B	11.35B	11.07B	11B	10.43B
Total Assets	4.28B	4.79B	4.46B	4.16B	6.18B
Brazil	3.48B	5.32B	4.97B	4.32B	4.38B
Total Assets	1.63B	1.84B	1.47B	1.07B	1.06B
Asia / Pacific (Excl.China)	4.99B	5.19B	4.74B	4.47B	4.05B
Total Assets	1.31B	1.2B	969M	862M	710M
China	3.86B	4.26B	3.62B	3.6B	3.47B
Total Assets	623M	675M	695M	579M	533M
Latin America (Excl. Brazil)	3.16B	3.97B	3.96B	3.76B	3.46B
Total Assets	1.22B	1.44B	1.3B	1.34B	1.26B
Germany	2.54B	2.48B	2.45B	2.41B	2.58B
Total Assets	15.46B	15.17B	15.2B	15.14B	11.4B
North America (Excl.United States)	1.56B	1.89B	1.67B	1.68B	1.63B
Total Assets	1.58B	1.48B	1.06B	894M	806M
Switzerland	542M	600M	567M	575M	485M
Total Assets	4.93B	4.66B	4.32B	4.43B	4.64B
Europe / Middle East / Africa	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Latin America	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Asia / Pacific	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Reconciliation	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
Operating Income	-	-	-	-	-
North America	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-